Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus
Jérome Granel,Helder Fernandes,Brigitte Bader-Meunier,Amandine Guth,Olivier Richer,Pascal Pillet,Guy Leverger,Stéphane Ducassou,Mony Fahd,Marlène Pasquet,Nathalie Garnier,Vincent Barlogis,Corinne Guitton,Eric Jeziorski,Caroline Thomas,Sophie Bayart,Nathalie Cheikh,Catherine Paillard,Wadih Abou Chahla,Pascal Chastagner,Bénédicte Neven,Frédéric Millot,Julien Lejeune,Valérie Li Thiao Te,Corinne Armari-Alla,Claire Briandet,Liana Carausu,Marianna Deparis,Christophe Piguet,Joy Benadiba,Aude Marie-Cardine,Jean-Louis Louis Stephan,Isabelle Pellier,Claire Pluchart,Eric Doré,Katell Michaux,Sebastien Heritier,Thierry M Leblanc,Nathalie Aladjidi
DOI: https://doi.org/10.1182/blood.2023021884
IF: 20.3
2024-01-17
Blood
Abstract:SLE occurs in 22% of children with ANA-associated AIC Children with age > 10 years and ANA titre > 1/160 must be long-term monitored for SLE Autoimmune cytopenia (AIC) in children may be associated with positive antinuclear antibodies (ANA) and may progress to systemic lupus erythematosus (SLE). We evaluated the risk of progression to SLE of childhood-onset ANA-associated AIC. In the French national prospective OBS'CEREVANCE cohort, the long-term outcome of children with ANA-associated AIC (ANA titer ≥ 1/160) and the subgroup of children who developed SLE were described. ANA were positive in 355/1803 (20%) children with AIC. With a median follow-up of 5.8 (0.1-29.6) years, 79/355 (22%) patients developed SLE at a median age of 14.5 (1.1-21.4) years; 20% of chronic immune thrombocytopenic purpura, 19% of autoimmune hemolytic anemia and 45% of Evans syndrome. No ANA-negative patients developed SLE. Severe manifestations of SLE were observed in 21 patients and 2 patients died. In multivariate analysis including patients with positive ANA within the first 3 months after AIC diagnosis, age > 10 years at AIC diagnosis (relative risk (RR): 3.67, 95% confidence interval (CI) 1.18; 11.4, P = 0.024) and ANA titer > 1/160 (RR: 5.28, 95% CI 1.20; 23.17, P = 0.027) were associated with the occurrence of SLE after AIC diagnosis. ANA-associated AIC is a risk factor for progression to SLE, especially in children with an initial ANA titer > 1/160 and an age > 10 years at AIC diagnosis. ANA screening should be recommended in children with AIC and ANA positive patients should be long-term monitored for SLE with a special attention on the transition period.
hematology